Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MARS2 | Q96GW9 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 3/20 | 0.52 |
| ▸ | RPLP1 | P05386 | 1/20 | 0.50 |
| ▸ | RPLP0 | P05388 | 1/20 | 0.50 |
| ▸ | RPS17 | P08708 | 1/20 | 0.50 |
| ▸ | RPSA | P08865 | 1/20 | 0.50 |
| ▸ | RPS2 | P15880 | 1/20 | 0.50 |
| ▸ | RPL35A | P18077 | 1/20 | 0.50 |
| ▸ | RPL7 | P18124 | 1/20 | 0.50 |
| ▸ | RPL17 | P18621 | 1/20 | 0.50 |
| ▸ | RPS4Y1 | P22090 | 1/20 | 0.50 |
| ▸ | RPS3 | P23396 | 1/20 | 0.50 |
| ▸ | RPS12 | P25398 | 1/20 | 0.50 |
| ▸ | RPL13 | P26373 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL334444 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL251728 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL29167395 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL12172739 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL14183583 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL4247918 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL4406664 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| SCHEMBL3912679 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| Hydrochloric Acid SCHEMBL11703545 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 | |
| Hydrochloric Acid SCHEMBL10626955 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP3A4LMNASMN1; SMN2MARS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | claimed |
| US-12233182-B2 | Instant underwater bio-adhesive containing catechol moieties and water-resistant cholesterol | CITY UNIVERSITY OF HONG KONG (HK) | 2025-02-25 | — | — | US | claimed |
| CN-117677605-B | Process for preparing levetiracetam and intermediates thereof | 苏州博希康医药科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240108782-A1 | AN INSTANT UNDERWATER BIO-ADHESIVE CONTAINING CATECHOL MOIETIES AND WATER-RESISTANT CHOLESTEROL | CITY UNIVERSITY OF HONG KONG (HK) | 2024-04-04 | — | — | US | claimed |
| CN-117677605-A | Process for preparing levetiracetam and intermediates thereof | 维生源知识产权有限责任公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117185938-A | Preparation process of (1R, 2R) -2-amino-1- (4-nitrophenyl) -1, 3-propanediol | 宁波酶赛生物工程有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-11286270-B2 | Boronic acid derivatives and synthesis thereof | QPEX BIOPHARMA, INC. (US) | 2022-03-29 | — | — | US | claimed |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA, INC. | 2020-12-31 | — | — | US | claimed |
| US-9737875-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-08-22 | — | — | US | claimed |
| EP-1644384-B1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF ENTECAVIR | BRISTOL MYERS SQUIBB CO (US) | 2012-10-31 | — | — | EP | claimed |
| US-20060106215-A1 | Process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | CHAN YEUNG Y | 2006-05-18 | — | — | US | claimed |
| EP-1644384-A2 | PROCESS AND INTERMEDIATES FOR SYNTHESIS ENTECAVIR | Bristol-Myers Squibb Company (US) | 2006-04-12 | — | — | EP | claimed |
| JP-2006509800-A | — | — | 2006-03-23 | — | — | JP | claimed |
| US-20060020022-A1 | Enantioselective separation method | PHARMACIA & UPJOHN COMPANY LLC | 2006-01-26 | — | — | US | claimed |
| US-20050033084-A1 | Resolution of alpha-(phenoxy)phenylacetic acid derivatives | METABOLEX, INC. (US) | 2005-02-10 | — | — | US | claimed |
| US-20050020834-A1 | Method for preparation of sulphostin and its analogue or intermediates thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2005-01-27 | — | — | US | claimed |
| US-20040242921-A1 | Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid | SANOFI (FR) | 2004-12-02 | — | — | US | claimed |
| US-20040192912-A1 | Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | BRISTOL-MYERS SQUIBB COMPANY | 2004-09-30 | — | — | US | claimed |
| EP-1457494-A1 | PROCESSES FOR PREPARATION OF SULPHOSTIN AND ITS ANALOGUES OR INTERMEDIATES THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2004-09-15 | — | — | EP | claimed |
| WO-2004052310-A2 | PROCESS AND INTERMEDIATES FOR SYNTHESIS ENTECAVIR | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-06-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020834-A1 | Method for preparation of sulphostin and its analogue or intermediates thereof | SOST, PTMS, FGF23 | ALDH1A1 3724/4885CYP3A4 2752/4885LMNA 1125/4885 |
| US-20040242921-A1 | Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid | GRHPR, HCAR2, HCAR1 | ALDH1A1 126/4885CYP3A4 245/4885LMNA 3718/4885 |
| US-20040192912-A1 | Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | SAMHD1, NUDT1, ENTPD1 | ALDH1A1 1031/4885CYP3A4 588/4885LMNA 2046/4885 |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | BTD, BLVRB, BLK | ALDH1A1 1025/4885CYP3A4 471/4885LMNA 562/4885 |
| US-20050033084-A1 | Resolution of alpha-(phenoxy)phenylacetic acid derivatives | PAH, PDGFA, PDGFRA | ALDH1A1 64/4885CYP3A4 691/4885LMNA 1939/4885 |
| US-11286270-B2 | Boronic acid derivatives and synthesis thereof | BTD, BLVRB, BLK | ALDH1A1 1025/4885CYP3A4 471/4885LMNA 562/4885 |
| US-20060106215-A1 | Process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | SAMHD1, NUDT1, ENTPD1 | ALDH1A1 976/4885CYP3A4 487/4885LMNA 2145/4885 |
| US-20060020022-A1 | Enantioselective separation method | SLC7A1, SLC10A1, DHCR7 | ALDH1A1 350/4885CYP3A4 86/4885LMNA 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.